INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 113 filers reported holding INTERSECT ENT INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,475,000 | -17.1% | 195,460 | -19.2% | 0.01% | -15.4% |
| Q4 2021 | $6,608,000 | +17.4% | 241,960 | +16.9% | 0.01% | +8.3% |
| Q3 2021 | $5,629,000 | +608.1% | 206,960 | +345.1% | 0.01% | +500.0% |
| Q2 2021 | $795,000 | -18.1% | 46,500 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $971,000 | -8.8% | 46,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,065,000 | +24.9% | 46,500 | -11.1% | 0.00% | 0.0% |
| Q3 2020 | $853,000 | +28.7% | 52,300 | +6.7% | 0.00% | 0.0% |
| Q2 2020 | $663,000 | -0.3% | 49,000 | -12.7% | 0.00% | 0.0% |
| Q1 2020 | $665,000 | -42.1% | 56,100 | +21.7% | 0.00% | -33.3% |
| Q4 2019 | $1,148,000 | +46.4% | 46,100 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $784,000 | -20.4% | 46,100 | +6.5% | 0.00% | -33.3% |
| Q2 2019 | $985,000 | -23.6% | 43,300 | +8.0% | 0.00% | -25.0% |
| Q1 2019 | $1,289,000 | +48.0% | 40,100 | +29.8% | 0.00% | +33.3% |
| Q4 2018 | $871,000 | +0.3% | 30,900 | +2.3% | 0.00% | +50.0% |
| Q3 2018 | $868,000 | -23.3% | 30,200 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $1,131,000 | +51.4% | 30,200 | +58.9% | 0.00% | +50.0% |
| Q1 2018 | $747,000 | +21.3% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $616,000 | +4.1% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $592,000 | +11.5% | 19,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $531,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|